TreeWAS – Variant ID: rs17444059

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.929	0.071	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.927	0.073	0.000
C78.7 Secondary malignant neoplasm of liver	0.916	0.084	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.884	0.116	0.000
C78.0 Secondary malignant neoplasm of lung	0.798	0.202	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.784	0.216	0.000
C78.2 Secondary malignant neoplasm of pleura	0.768	0.232	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.710	0.290	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.666	0.334	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.663	0.337	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.285	0.715	0.000
C80 Malignant neoplasm without specification of site	0.237	0.762	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.226	0.774	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.200	0.800	0.000
C79 Secondary malignant neoplasm of other sites	0.198	0.802	0.000
C79.6 Secondary malignant neoplasm of ovary	0.183	0.817	0.000
C76.2 Abdomen	0.178	0.822	0.000
C80.9 Malignant neoplasm, unspecified	0.176	0.824	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.174	0.826	0.000
C76.0 Head, face and neck	0.169	0.831	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.162	0.838	0.000
C76.7 Other ill-defined sites	0.162	0.838	0.000
C76.5 Lower limb	0.162	0.838	0.000
C76.4 Upper limb	0.162	0.838	0.000
C76.3 Pelvis	0.162	0.838	0.000
C76.1 Thorax	0.162	0.838	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.161	0.839	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.148	0.852	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.134	0.866	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.124	0.876	0.000
C79.2 Secondary malignant neoplasm of skin	0.119	0.880	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.118	0.882	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.105	0.895	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.038	0.962	0.000
E86 Volume depletion	0.013	0.987	0.000
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.000	0.989	0.011
N48.2 Other inflammatory disorders of penis	0.011	0.989	0.000
N48 Other disorders of penis	0.011	0.989	0.000
N48.6 Balanitis xerotica obliterans	0.011	0.989	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.010	0.990	0.000
N48.8 Other specified disorders of penis	0.010	0.990	0.000
N48.5 Ulcer of penis	0.010	0.990	0.000
N48.4 Impotence of organic origin	0.009	0.991	0.000
C77.9 Lymph node, unspecified	0.009	0.991	0.000
N48.1 Balanoposthitis	0.009	0.991	0.000
N48.3 Priapism	0.009	0.991	0.000
N48.9 Disorder of penis, unspecified	0.008	0.992	0.000
N48.0 Leukoplakia of penis	0.008	0.992	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.993	0.007
C77.8 Lymph nodes of multiple regions	0.007	0.993	0.000
S01.9 Open wound of head, part unspecified	0.006	0.994	0.000
C77.4 Inguinal and lower limb lymph nodes	0.006	0.994	0.000
C77.3 Axillary and upper limb lymph nodes	0.006	0.994	0.000
F33.9 Recurrent depressive disorder, unspecified	0.006	0.994	0.000
M54.59 Low back pain (Site unspecified)	0.000	0.994	0.006
E11.4 With neurological complications	0.000	0.995	0.005
B44.1 Other pulmonary aspergillosis	0.005	0.995	0.000
F33 Recurrent depressive disorder	0.005	0.995	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.005	0.995	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
H04.2 Epiphora	0.000	0.995	0.005
B44.9 Aspergillosis, unspecified	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
R72 Abnormality of white blood cells, not elsewhere classified	0.005	0.995	0.000
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
B44 Aspergillosis	0.005	0.995	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.004	0.996	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.004	0.996	0.000
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
C77.1 Intrathoracic lymph nodes	0.004	0.996	0.000
M54.56 Low back pain (Lumbar region)	0.000	0.996	0.004
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.004	0.996	0.000
M54.5 Low back pain	0.000	0.996	0.004
T38.1 Thyroid hormones and substitutes	0.004	0.996	0.000
H81.1 Benign paroxysmal vertigo	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.996	0.004
T42.4 Benzodiazepines	0.004	0.996	0.000
H25.8 Other senile cataract	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
F33.8 Other recurrent depressive disorders	0.004	0.996	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.004	0.996	0.000
H92.0 Otalgia	0.000	0.996	0.004
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
Z29.0 Isolation	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
M54.50 Low back pain (Multiple sites in spine)	0.000	0.996	0.004
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.004	0.996	0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.004	0.996	0.000
B44.8 Other forms of aspergillosis	0.003	0.996	0.000
B44.7 Disseminated aspergillosis	0.003	0.996	0.000
B44.2 Tonsillar aspergillosis	0.003	0.996	0.000
B44.0 Invasive pulmonary aspergillosis	0.003	0.996	0.000
H92.1 Otorrhoea	0.000	0.996	0.004
H92 Otalgia and effusion of ear	0.000	0.996	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
C77.5 Intrapelvic lymph nodes	0.003	0.997	0.000
M54.55 Low back pain (Thoracolumbar region)	0.000	0.997	0.003
M54.54 Low back pain-Thoracic	0.000	0.997	0.003
M54.53 Low back pain-Cervicothoracic	0.000	0.997	0.003
M54.52 Low back pain-Cervical	0.000	0.997	0.003
M54.51 Low back pain-Occipit-atl-axl	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.003	0.997	0.000
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.997	0.003
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
E88 Other metabolic disorders	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.997	0.003
M54.57 Low back pain (Lumbosacral region)	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.997	0.003
H92.2 Otorrhagia	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
M54.99 Dorsalgia, unspecified (Site unspecified)	0.000	0.997	0.003
T42.1 Iminostilbenes	0.003	0.997	0.000
Z94.0 Kidney transplant status	0.003	0.997	0.000
G59.0 Diabetic mononeuropathy	0.000	0.997	0.003
R74 Abnormal serum enzyme levels	0.003	0.997	0.000
B07 Viral warts	0.003	0.997	0.000
Z22.3 Carrier of other specified bacterial diseases	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.997	0.000
E89.3 Postprocedural hypopituitarism	0.003	0.997	0.000
E88.9 Metabolic disorder, unspecified	0.002	0.997	0.000
J98.1 Pulmonary collapse	0.000	0.997	0.003
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.997	0.003
T45.5 Anticoagulants	0.002	0.997	0.000
T36 Poisoning by systemic antibiotics	0.002	0.997	0.000
B35-B49 Mycoses	0.003	0.997	0.000
R70-R79 Abnormal findings on examination of blood, without diagnosis	0.003	0.997	0.000
R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]	0.002	0.997	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.002	0.997	0.000
H04 Disorders of lachrymal system	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.997	0.000
J98.9 Respiratory disorder, unspecified	0.000	0.998	0.002
R74.8 Abnormal levels of other serum enzymes	0.002	0.998	0.000
R78 Findings of drugs and other substances, not normally found in blood	0.002	0.998	0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.000	0.998	0.002
H81.8 Other disorders of vestibular function	0.002	0.998	0.000
Z22.1 Carrier of other intestinal infectious diseases	0.002	0.998	0.000
H81 Disorders of vestibular function	0.002	0.998	0.000
M79.79 Fibromyalgia (Site unspecified)	0.000	0.998	0.002
R78.0 Finding of alcohol in blood	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
E88.8 Other specified metabolic disorders	0.002	0.998	0.000
E88.3 Tumour lysis syndrome	0.002	0.998	0.000
E88.2 Lipomatosis, not elsewhere classified	0.002	0.998	0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
H90 Conductive and sensorineural hearing loss	0.000	0.998	0.002
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
R77 Other abnormalities of plasma proteins	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
B49 Unspecified mycosis	0.002	0.998	0.000
C77.0 Lymph nodes of head, face and neck	0.002	0.998	0.000
H47.1 Papilloedema, unspecified	0.002	0.998	0.000
Z97.4 Presence of external hearing-aid	0.000	0.998	0.002
Z29 Need for other prophylactic measures	0.002	0.998	0.000
H90.3 Sensorineural hearing loss, bilateral	0.000	0.998	0.002
T40.2 Other opioids	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
B37.9 Candidiasis, unspecified	0.002	0.998	0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
J98 Other respiratory disorders	0.000	0.998	0.002
Z22 Carrier of infectious disease	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.002	0.998	0.000
R76 Other abnormal immunological findings in serum	0.002	0.998	0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.000	0.998	0.002
M54.4 Lumbago with sciatica	0.000	0.998	0.002
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
R76.8 Other specified abnormal immunological findings in serum	0.002	0.998	0.000
Z43.3 Attention to colostomy	0.000	0.998	0.002
J44.9 Chronic obstructive pulmonary disease, unspecified	0.002	0.998	0.000
H90.5 Sensorineural hearing loss, unspecified	0.000	0.998	0.002
R77.1 Abnormality of globulin	0.002	0.998	0.000
M13.94 Arthritis, unspecified (Hand)	0.000	0.998	0.002
E89.4 Postprocedural ovarian failure	0.002	0.998	0.000
J98.4 Other disorders of lung	0.000	0.998	0.002
B36 Other superficial mycoses	0.002	0.998	0.000
J42 Unspecified chronic bronchitis	0.000	0.998	0.002
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.002	0.998	0.000
R74.9 Abnormal level of unspecified serum enzyme	0.002	0.998	0.000
H90-H95 Other disorders of ear	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.002	0.998	0.000
H47.3 Other disorders of optic disk	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
B37 Candidiasis	0.002	0.998	0.000
H04.8 Other disorders of lachrymal system	0.000	0.998	0.002
H04.3 Acute and unspecified inflammation of lachrymal passages	0.000	0.998	0.002
B48 Other mycoses, not elsewhere classified	0.002	0.998	0.000
B47 Mycetoma	0.002	0.998	0.000
B46 Zygomycosis	0.002	0.998	0.000
B45 Cryptococcosis	0.002	0.998	0.000
B43 Chromomycosis and phaeomycotic abscess	0.002	0.998	0.000
B42 Sporotrichosis	0.002	0.998	0.000
B41 Paracoccidioidomycosis	0.002	0.998	0.000
B40 Blastomycosis	0.002	0.998	0.000
B39 Histoplasmosis	0.002	0.998	0.000
B38 Coccidioidomycosis	0.002	0.998	0.000
R75 Laboratory evidence of human immunodeficiency virus [HIV]	0.002	0.998	0.000
R78.8 Finding of other specified substances, not normally found in blood	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
S42.00 Fracture of clavicle (closed)	0.002	0.998	0.000
H04.9 Disorder of lachrymal system, unspecified	0.000	0.998	0.002
H04.6 Other changes in lachrymal passages	0.000	0.998	0.002
H04.0 Dacryoadenitis	0.000	0.998	0.002
E70-E90 Metabolic disorders	0.002	0.998	0.000
J98.8 Other specified respiratory disorders	0.000	0.998	0.002
L03.3 Cellulitis of trunk	0.002	0.998	0.000
R78.9 Finding of unspecified substance, not normally found in blood	0.002	0.998	0.000
R78.7 Finding of abnormal level of heavy metals in blood	0.002	0.998	0.000
R78.6 Finding of steroid agent in blood	0.002	0.998	0.000
R78.5 Finding of psychotropic drug in blood	0.002	0.998	0.000
R78.4 Finding of other drugs of addictive potential in blood	0.002	0.998	0.000
R78.3 Finding of hallucinogen in blood	0.002	0.998	0.000
R78.2 Finding of cocaine in blood	0.002	0.998	0.000
R78.1 Finding of opiate drug in blood	0.002	0.998	0.000
H81.4 Vertigo of central origin	0.002	0.998	0.000
H81.3 Other peripheral vertigo	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
B37.4 Candidiasis of other urogenital sites	0.002	0.998	0.000
R77.8 Other specified abnormalities of plasma proteins	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
Z29.2 Other prophylactic chemotherapy	0.002	0.998	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.002	0.998	0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
E89.2 Postprocedural hypoparathyroidism	0.002	0.998	0.000
J98.6 Disorders of diaphragm	0.000	0.998	0.002
R77.2 Abnormality of alphafetoprotein	0.002	0.998	0.000
R77.0 Abnormality of albumin	0.002	0.998	0.000
R70.1 Abnormal plasma viscosity	0.002	0.998	0.000
R77.9 Abnormality of plasma protein, unspecified	0.002	0.998	0.000
Z22.8 Carrier of other infectious diseases	0.002	0.998	0.000
Z29.9 Prophylactic measure, unspecified	0.002	0.998	0.000
F60 Specific personality disorders	0.002	0.998	0.000
B36.9 Superficial mycosis, unspecified	0.002	0.998	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.002	0.998	0.000
M79.0 Rheumatism, unspecified	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
H90.2 Conductive hearing loss, unspecified	0.000	0.998	0.002
J98.3 Compensatory emphysema	0.000	0.998	0.002
J98.2 Interstitial emphysema	0.000	0.998	0.002
S43.0 Dislocation of shoulder joint	0.002	0.998	0.000
Z22.9 Carrier of infectious disease, unspecified	0.002	0.998	0.000
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.002	0.998	0.000
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.002	0.998	0.000
Z22.2 Carrier of diphtheria	0.002	0.998	0.000
Z22.0 Carrier of typhoid	0.002	0.998	0.000
O94-O99 Other obstetric conditions, not elsewhere classified	0.000	0.998	0.002
M79.89 Other specified soft tissue disorders (Site unspecified)	0.000	0.998	0.002
A02.0 Salmonella gastro-enteritis	0.002	0.998	0.000
E23.2 Diabetes insipidus	0.002	0.998	0.000
E23.0 Hypopituitarism	0.002	0.998	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.002	0.998	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.002	0.998	0.000
E89.5 Postprocedural testicular hypofunction	0.002	0.998	0.000
E89.1 Postprocedural hypoinsulinaemia	0.002	0.998	0.000
H81.9 Disorder of vestibular function, unspecified	0.002	0.998	0.000
J98.0 Diseases of bronchus, not elsewhere classified	0.000	0.998	0.002
R76.9 Abnormal immunological finding in serum, unspecified	0.002	0.998	0.000
R76.2 False-positive serological test for syphilis	0.002	0.998	0.000
R76.1 Abnormal reaction to tuberculin test	0.002	0.998	0.000
M54 Dorsalgia	0.000	0.998	0.002
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.000	0.998	0.002
M54.44 Lumbago with sciatica-Thoracic	0.000	0.998	0.002
M54.43 Lumbago with sciatica-Cervicothoracic	0.000	0.998	0.002
M54.42 Lumbago with sciatica-Cervical	0.000	0.998	0.002
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.000	0.998	0.002
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.000	0.998	0.002
F60.5 Anankastic personality disorder	0.002	0.998	0.000
H81.2 Vestibular neuronitis	0.002	0.998	0.000
T36.0 Penicillins	0.002	0.998	0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.000	0.998	0.002
E84 Cystic fibrosis	0.002	0.998	0.000
B36.8 Other specified superficial mycoses	0.002	0.998	0.000
B36.3 Black piedra	0.002	0.998	0.000
B36.2 White piedra	0.002	0.998	0.000
B36.1 Tinea nigra	0.002	0.998	0.000
B36.0 Pityriasis versicolor	0.002	0.998	0.000
H90.0 Conductive hearing loss, bilateral	0.000	0.998	0.002
B35 Dermatophytosis	0.002	0.998	0.000
M79.18 Myalgia (Other)	0.000	0.998	0.002
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.002	0.998	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.002	0.998	0.000
H94 Other disorders of ear in diseases classified elsewhere	0.000	0.998	0.002
B37.1 Pulmonary candidiasis	0.002	0.998	0.000
E23 Hypofunction and other disorders of pituitary gland	0.002	0.998	0.000
H91.8 Other specified hearing loss	0.000	0.998	0.002
L85.9 Epidermal thickening, unspecified	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.000	0.998	0.002
B37.7 Candidal septicaemia	0.002	0.998	0.000
B37.6 Candidal endocarditis	0.002	0.998	0.000
B37.5 Candidal meningitis	0.002	0.998	0.000
B38.9 Coccidioidomycosis, unspecified	0.002	0.998	0.000
B38.8 Other forms of coccidioidomycosis	0.002	0.998	0.000
B38.7 Disseminated coccidioidomycosis	0.002	0.998	0.000
B38.4 Coccidioidomycosis meningitis	0.002	0.998	0.000
B38.3 Cutaneous coccidioidomycosis	0.002	0.998	0.000
B38.2 Pulmonary coccidioidomycosis, unspecified	0.002	0.998	0.000
B38.1 Chronic pulmonary coccidioidomycosis	0.002	0.998	0.000
B38.0 Acute pulmonary coccidioidomycosis	0.002	0.998	0.000
B39.9 Histoplasmosis, unspecified	0.002	0.998	0.000
B39.5 Histoplasmosis duboisii	0.002	0.998	0.000
B39.4 Histoplasmosis capsulati, unspecified	0.002	0.998	0.000
B39.3 Disseminated histoplasmosis capsulati	0.002	0.998	0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.002	0.998	0.000
B39.1 Chronic pulmonary histoplasmosis capsulati	0.002	0.998	0.000
B39.0 Acute pulmonary histoplasmosis capsulati	0.002	0.998	0.000
B40.9 Blastomycosis, unspecified	0.002	0.998	0.000
B40.8 Other forms of blastomycosis	0.002	0.998	0.000
B40.7 Disseminated blastomycosis	0.002	0.998	0.000
B40.3 Cutaneous blastomycosis	0.002	0.998	0.000
B40.2 Pulmonary blastomycosis, unspecified	0.002	0.998	0.000
B40.1 Chronic pulmonary blastomycosis	0.002	0.998	0.000
B40.0 Acute pulmonary blastomycosis	0.002	0.998	0.000
B41.9 Paracoccidioidomycosis, unspecified	0.002	0.998	0.000
B41.8 Other forms of paracoccidioidomycosis	0.002	0.998	0.000
B41.7 Disseminated paracoccidioidomycosis	0.002	0.998	0.000
B41.0 Pulmonary paracoccidioidomycosis	0.002	0.998	0.000
B42.9 Sporotrichosis, unspecified	0.002	0.998	0.000
B42.8 Other forms of sporotrichosis	0.002	0.998	0.000
B42.7 Disseminated sporotrichosis	0.002	0.998	0.000
B42.1 Lymphocutaneous sporotrichosis	0.002	0.998	0.000
B42.0 Pulmonary sporotrichosis	0.002	0.998	0.000
B43.9 Chromomycosis, unspecified	0.002	0.998	0.000
B43.8 Other forms of chromomycosis	0.002	0.998	0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.002	0.998	0.000
B43.1 Phaeomycotic brain abscess	0.002	0.998	0.000
B43.0 Cutaneous chromomycosis	0.002	0.998	0.000
B45.9 Cryptococcosis, unspecified	0.002	0.998	0.000
B45.8 Other forms of cryptococcosis	0.002	0.998	0.000
B45.7 Disseminated cryptococcosis	0.002	0.998	0.000
B45.3 Osseous cryptococcosis	0.002	0.998	0.000
B45.2 Cutaneous cryptococcosis	0.002	0.998	0.000
B45.1 Cerebral cryptococcosis	0.002	0.998	0.000
B45.0 Pulmonary cryptococcosis	0.002	0.998	0.000
B46.9 Zygomycosis, unspecified	0.002	0.998	0.000
B46.8 Other zygomycoses	0.002	0.998	0.000
B46.5 Mucormycosis, unspecified	0.002	0.998	0.000
B46.4 Disseminated mucormycosis	0.002	0.998	0.000
B46.3 Cutaneous mucormycosis	0.002	0.998	0.000
B46.2 Gastro-intestinal mucormycosis	0.002	0.998	0.000
B46.1 Rhinocerebral mucormycosis	0.002	0.998	0.000
B46.0 Pulmonary mucormycosis	0.002	0.998	0.000
B47.9 Mycetoma, unspecified	0.002	0.998	0.000
B47.1 Actinomycetoma	0.002	0.998	0.000
B47.0 Eumycetoma	0.002	0.998	0.000
B48.8 Other specified mycoses	0.002	0.998	0.000
B48.7 Opportunistic mycoses	0.002	0.998	0.000
B48.4 Penicillosis	0.002	0.998	0.000
B48.3 Geotrichosis	0.002	0.998	0.000
B48.2 Allescheriasis	0.002	0.998	0.000
B48.1 Rhinosporidiosis	0.002	0.998	0.000
B48.0 Lobomycosis	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
H91 Other hearing loss	0.000	0.998	0.002
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.001	0.998	0.000
H93 Other disorders of ear, not elsewhere classified	0.000	0.998	0.002
M54.16 Radiculopathy (Lumbar region)	0.002	0.998	0.000
E79 Disorders of purine and pyrimidine metabolism	0.002	0.998	0.000
E77 Disorders of glycoprotein metabolism	0.002	0.998	0.000
E76 Disorders of glycosaminoglycan metabolism	0.002	0.998	0.000
E72 Other disorders of amino-acid metabolism	0.002	0.998	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.002	0.998	0.000
E70 Disorders of aromatic amino-acid metabolism	0.002	0.998	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.002	0.998	0.000
B37.2 Candidiasis of skin and nail	0.002	0.998	0.000
E84.9 Cystic fibrosis, unspecified	0.002	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.002	0.998	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.002	0.998	0.000
N18.0 End-stage renal disease	0.002	0.998	0.000
O82.1 Delivery by emergency Caesarean section	0.002	0.998	0.000
E74 Other disorders of carbohydrate metabolism	0.002	0.998	0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.002	0.998	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.000	0.998	0.002
H47.7 Disorder of visual pathways, unspecified	0.002	0.998	0.000
H47.6 Disorders of visual cortex	0.002	0.998	0.000
H47.5 Disorders of other visual pathways	0.002	0.998	0.000
H47.4 Disorders of optic chiasm	0.002	0.998	0.000
H93.9 Disorder of ear, unspecified	0.000	0.998	0.002
M79.7 Fibromyalgia	0.000	0.998	0.002
S82.40 Fracture of fibula alone (closed)	0.000	0.998	0.002
C77.2 Intra-abdominal lymph nodes	0.002	0.998	0.000
F60.7 Dependent personality disorder	0.002	0.998	0.000
M54.8 Other dorsalgia	0.000	0.998	0.002
R76.0 Raised antibody titer	0.001	0.998	0.000
Z29.8 Other specified prophylactic measures	0.002	0.998	0.000
B35.1 Tinea unguium	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations